Omega-3: what the evidence actually shows

declining omega-3 — attention cooling after large mixed/null trials

Reviewed by Substrate editorial, Independent research collective · 2026-07-16

⚠ Safety in context

seriouswith Warfarin: High-dose omega-3 with warfarin may increase bleeding risk.

Evidence by outcome

heart healthgrade Bmoderate certainty— modest cardiovascular benefit; large recent trials were mixed

inflammationgrade Bmoderate certainty— lowers inflammation markers in the blood; bigger doses have a bigger effect

joint healthgrade Bmoderate certainty— reduces joint tenderness / morning stiffness in rheumatoid arthritis

blood sugargrade Bmoderate certainty— Meta-analysis in type 2 diabetes: results for omega-3 on glucose control were mixed and, overall, no consistent improvement in glycemic control was demonstrated. The authors note the EPA/DHA ratio and early intervention may modify effects — a subgroup signal, not a general glucose benefit.

moodgrade Cmoderate certainty— small benefit for depressive symptoms, clearest with higher-EPA formulations

skingrade Dvery-low certainty— Narrative review: omega-3 fatty acids have plausible dermatological roles (skin barrier, inflammation modulation, photoprotection), but controlled clinical evidence that supplementation improves specific skin outcomes is limited and preliminary.

cognitionnot well studiedvery-low certainty— not adequately studied for cognition in healthy adults

People say · Evidence shows

“Fish oil prevents heart attacks”

aheadlargemarketing claim

What it probably doesn't do

Omega-3 for skin — Grade D, Narrative review: omega-3 fatty acids have plausible dermatological roles (skin barrier, inflammation modulation, photoprotection), but controlled clinical evidence that supplementation improves specific skin outcomes is limited and preliminary..

Grade history

2026-07-16B → BSource correction by Claude (b2 garbage-source correction): replaced an off-topic search-fallback source (published before the pump's topica details →
2026-07-16C → CMerged additional source by Claude (gold-standard provenance sweep): a distinct, independently-verified paper ("ω-3 Fatty acids for major de details →
2026-07-16B → BCorrection by Claude (gold-standard provenance sweep): live Postgres source drift replaced with the verified seed source set [pmid-35914448] details →
2026-07-16C → CCorrection by Claude (gold-standard provenance sweep): live Postgres source drift replaced with the verified seed source set [pmid-37028202] details →
2026-07-16B → BCorrection by Claude (gold-standard provenance sweep): live Postgres source drift replaced with the verified seed source set [pmid:29387889] details →

full change history

Re-review cadence: every 12 months (Grade A/B) · next scheduled by 2027-07-16 · methodology v1.

By outcome — the money pages

Compare

sources: PMID:29387889 · PMID:35914448 · PMID:17335973 · PMID:26431431 · PMID:37028202 · PMID:26936905 · PMID:32463305

Cite this page

Reuse under CC-BY 4.0 with attribution to evidencebased.info.

Plain-text citation

Substrate. Omega-3: what the evidence actually shows. https://evidencebased.info/interventions/omega-3. Updated 2026-07-16.

BibTeX

@misc{substrate_ointerventionsomega3,
  author = {Substrate editorial},
  title  = {Omega-3: what the evidence actually shows},
  year   = {2026},
  url    = {https://evidencebased.info/interventions/omega-3},
  note   = {evidencebased.info}
}